The first 7,000 doses of Long-Acting Antibody (LAAB) to prevent severe Covid-19 Coronavirus will arrive in Thailand next week, the Department of Disease Control revealed on Monday, July 18th.
Dr. Opas Karnkawinpong, director-general of the Department of Disease Control, said that the first lot of AstraZeneca’s LAAB will primarily be provided to the vulnerable group, including patients with chronic kidney disease, undergoing kidney dialysis, taking immunosuppressants, and those with organ transplants.
The first lot will arrive next Monday, July 25th. An additional amount of the antibody will gradually arrive in the country until reaching a total of 257,500 doses, according to the Director-General.
The Department expected that approximately 200,000 patients in the vulnerable group would register for the injections. Once injected, the antibody will be activated and last up to six months.
Follow us on Facebook